IQSM | VXF | IQSM / VXF | |
Gain YTD | 10.022 | 17.600 | 57% |
Net Assets | 225M | 120B | 0% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 13.00 | 11.00 | 118% |
Yield | 1.04 | 1.20 | 87% |
Fund Existence | 2 years | 23 years | - |
IQSM | VXF | |
---|---|---|
RSI ODDS (%) | 3 days ago89% | 3 days ago90% |
Stochastic ODDS (%) | 3 days ago89% | 3 days ago90% |
Momentum ODDS (%) | 3 days ago63% | 3 days ago81% |
MACD ODDS (%) | 3 days ago67% | 3 days ago88% |
TrendWeek ODDS (%) | 3 days ago62% | 3 days ago82% |
TrendMonth ODDS (%) | 3 days ago63% | 3 days ago82% |
Advances ODDS (%) | 24 days ago75% | 28 days ago86% |
Declines ODDS (%) | 20 days ago65% | 4 days ago85% |
BollingerBands ODDS (%) | 3 days ago79% | 3 days ago90% |
Aroon ODDS (%) | 3 days ago71% | 3 days ago86% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ESMV | 28.00 | 0.24 | +0.86% |
iShares ESG MSCI USA Min Vol Factor ETF | |||
BMAR | 46.20 | 0.38 | +0.83% |
Innovator U.S. Equity Buffer ETF™ - Mar | |||
LEAD | 67.41 | 0.37 | +0.56% |
Siren DIVCON Leaders Dividend ETF | |||
ESGE | 33.78 | 0.15 | +0.45% |
iShares ESG Aware MSCI EM ETF | |||
PPH | 86.54 | -0.40 | -0.46% |
VanEck Pharmaceutical ETF |
A.I.dvisor indicates that over the last year, IQSM has been closely correlated with FBIN. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQSM jumps, then FBIN could also see price increases.
Ticker / NAME | Correlation To IQSM | 1D Price Change % | ||
---|---|---|---|---|
IQSM | 100% | -4.20% | ||
FBIN - IQSM | 78% Closely correlated | +1.62% | ||
PNR - IQSM | 77% Closely correlated | +0.96% | ||
MAS - IQSM | 76% Closely correlated | +2.34% | ||
JLL - IQSM | 75% Closely correlated | +2.35% | ||
BLD - IQSM | 73% Closely correlated | +0.43% | ||
More |